Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
about
Psychosocial impact of chronic infection with hepatitis B virus on British patients.Interferon monotherapy in chronic hepatitis B.Advances in interferon research - Medical Staff Conference.Antiviral treatment in chronic infection with hepatitis B virus.Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver.Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infectionPreliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infection.Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination.Effect of adenine arabinoside and alpha-interferon in patients with HBeAg-positive chronic active hepatitisSelecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen.Alpha-interferon therapy for chronic hepatitis B virus infection in children and Oriental patients.Inactivation of S-adenosylhomocysteine hydrolase during adenine arabinoside therapyManagement of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?A review of the efficacy of adenine arabinoside and lymphoblastoid interferon in the Royal Free Hospital studies of hepatitis B virus carrier treatment: identification of factors influencing response rates.Randomised placebo controlled trials in HIV infection: to be or not to be?In vitro and in vivo comparison of the abilities of purine and pyrimidine 2',3'-dideoxynucleosides to inhibit duck hepadnavirus.Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase.Targeting of antiviral drugs by coupling with protein carriers.Pilot study of recombinant human interleukin 2 for chronic type B hepatitis.A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication.Interferon in the management of chronic hepatitis B.Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.25 years of interferon-based treatment of chronic hepatitis C: an epoch coming to an end.Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B.Interferon in viral hepatitis: role in pathogenesis and treatment.Inhibition of hepatitis B virus DNA polymerase by 3'-fluorothymidine triphosphate and other modified nucleoside triphosphate analogs.YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine.Acute hepatitis A infection in hepatitis B chimpanzee carriers.Diagnostic value of anti-HBc IgM in high HBV prevalence areas.Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection.Relationship of the effects of interferon on chronic hepatitis B and the induction of 2',5'-oligoadenylate synthetase.Evaluation of anti-hepadnavirus activity of Phyllanthus amarus and Phyllanthus maderaspatensis in duck hepatitis B virus carrier Pekin ducks.Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon.Non-A, non-B hepatitis in persistent carriers of hepatitis B virus.Comment: Alpha-interferon in treating chronic hepatitis B virus infection.Analysis of DNA polymerase reaction products for detecting hepatitis B virus in serum--comparison with spot hybridization technique.Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection.The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in man.Controlled clinical trial of acyclovir in chronic hepatitis B virus infection.Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon.
P2860
Q33582879-AE7782D9-BB50-4D75-9017-8B2213BA9413Q33988044-4C7235F0-B73D-4B47-AC6A-15A53752BC6AQ34111204-2580E0A0-EB1D-4B56-BEA8-040FAF1E8DA7Q34284781-5C2F7FFC-7FA6-4393-B351-5B33B472ADE4Q34496445-95507D99-DB78-4CA4-A9C9-52FD4F49CAEBQ34527992-6458D243-0663-4572-9C9D-CEA551EB0A7AQ35648540-2EE857DF-70E9-4271-BA9E-97E1FF3D53A2Q35673176-84000442-D243-4756-8C74-CD421B7F2931Q35948656-DF982335-B8F2-4913-96FB-02477BAB0E58Q36278947-B038495A-044E-4D4D-90EF-4FA4E7514042Q36828542-7DEC5D1B-9D77-4D62-9739-DF49A3BBCD5CQ37014410-32C647B7-C09D-46E4-BB4E-3F67CD19B201Q37958234-0E154FFD-9C4A-4B00-A17D-9F13B421E917Q38176203-7DA2DE50-61D7-48F0-974F-B2624BC121F7Q38673106-329D2D75-898B-42B3-9C38-CD3EFA61B0DBQ39815058-FFE979AB-3F80-491F-9164-D105B89F749AQ39833860-1D8AF504-6B90-475F-A935-9DF04E31595EQ40105814-4D5A5949-1D25-4DE9-89B1-C3A59158758AQ40786738-7079B39E-E77C-4E11-A20A-5390BC4303DBQ40814496-2DDA377F-B488-4D9A-8FA1-3BB97E6D219AQ40891677-0497CB75-DFDF-400E-8B8D-C46F372A1C33Q42124203-79733A3E-D2F2-4ED7-8CCF-CDD86C3FB378Q42992965-61F26186-426E-4147-848B-348AE6F25EC5Q43206457-609BF1F0-6007-455B-B66A-EB103A19F7ABQ44001359-FEA00E24-9643-4EEE-83F1-2706B7B0EA07Q44257008-CAC00D4F-7987-4FF6-A8AC-20479B59264AQ44404478-E62E662C-5822-446A-9A73-B92E5801AFDBQ44595797-D13C3448-1A45-474D-9117-E67FB64F077BQ44596198-33E58E3A-CFF2-4654-9D06-06E75FFBD3F3Q44812898-DF909CEF-0D2F-4B0B-928E-1147DAD9E8D4Q45061612-1446A6E4-EE44-4B85-9DA6-7C9F1E6FB6C3Q45779734-7FE17458-7313-4AB3-B857-BA996C965E88Q45795541-C8890E3A-7435-4B39-AE19-DADA11956183Q45795852-3D0D706C-F9AA-4C49-9531-C3D667999DE0Q45828334-D5C64C57-A96B-4C72-B26D-CD23C7C67547Q45828511-7D6F9229-4AE8-4961-96B4-7CD581971D85Q45829254-62BE8902-4A31-42D7-847F-5B1A2000021CQ45830455-9ED610D8-2EA8-434F-89D6-6818A737A5DDQ45830878-25BEC67D-7B65-413A-842B-CDC43087B38FQ45834520-6E6401ED-29C8-4D37-8D93-2D3F0B50A416
P2860
Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh-hant
name
Antiviral treatment of chronic ...... ined with adenine arabinoside.
@en
Antiviral treatment of chronic ...... ined with adenine arabinoside.
@nl
type
label
Antiviral treatment of chronic ...... ined with adenine arabinoside.
@en
Antiviral treatment of chronic ...... ined with adenine arabinoside.
@nl
prefLabel
Antiviral treatment of chronic ...... ined with adenine arabinoside.
@en
Antiviral treatment of chronic ...... ined with adenine arabinoside.
@nl
P2093
P356
P1476
Antiviral treatment of chronic ...... ined with adenine arabinoside.
@en
P2093
Gregory PB
Merigan TC
Pollard RB
Robinson WS
Scullard GH
P304
P356
10.1093/INFDIS/143.6.772
P407
P577
1981-06-01T00:00:00Z